Carisma Therapeutics to Present at Upcoming Healthcare Industry and Investor Conferences in April 2023

PHILADELPHIA, April 6, 2023 /PRNewswire/ — Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will participate at several conferences in April 2023.

Upcoming healthcare industry conferences include:

2023 Cell & Gene Meeting on the Med

• Tom Wilton, Chief Business Officer, will give a corporate presentation.
• Thursday, April 13, 2023 at 10:45 am CET
• Barcelona, Spain

American Association for Cancer Research (AACR) Annual Meeting 2023

• Carisma will present three data abstracts during the meeting:
• Macrophages engineered with cytokine switch receptors: Development of a modular platform for rebalancing inflammation in microenvironments;
• A mesothelin targeting chimeric antigen receptor macrophage (CAR-M) for solid tumor immunotherapy: pre-clinical development of CT-1119; and
• A Phase 1, First-in-Human study of autologous anti-HER2 CAR-M in participants with HER2 overexpressing solid tumors.
• Friday, April …

Full story available on Benzinga.com

therapeutics
immunotherapy
biopharmaceutical
healthcare
nasdaq